25. Future Oncol. 2018 Jul 18. doi: 10.2217/fon-2018-0185. [Epub ahead of print]Tailoring breast cancer therapies to reduce mortality and improve quality oflife: San Antonio Breast Cancer Symposium 2017 (part 1).Benson JR(1), Jatoi I(2).Author information: (1)Cambridge University Hospitals NHS Foundation Trust, University of Cambridgeand School of Medicine, Anglia Ruskin University, Cambridge, UK.(2)Division of Surgical Oncology, Dale H Dorn Chair in Surgery, University ofTexas Health Science Center, San Antonio, TX, USA.The 40th annual San Antonio Breast Cancer Symposium was convened in San Antonio, Texas on 5-9 December 2017. More than 7500 clinicians and scientists from around the world participated in the symposium which featured a range of presentationsand keynote talks pertaining to breast cancer screening, prevention,loco-regional and systemic therapies. This two-part report highlights a selectionof important studies presented at this premier breast cancer event with part 1focusing on dose-intense radiotherapy, perioperative endocrine therapy, duration of bisphosphonates, immunotherapy, ovarian function suppression and acupuncture. The second part of this report will discuss a range of topics related tode-escalation of loco-regional therapies, the significance of completepathological response, older patients and CDK 4/6 inhibitors, circulating tumorcells and plasma DNA as a tumor marker.DOI: 10.2217/fon-2018-0185 PMID: 30019918 